Inverness Medical Innovations to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference on March 2, 2010

WALTHAM, Mass., Feb. 24 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the J.P. Morgan Global High Yield & Leveraged Finance Conference being held on March 1 through 3, 2010 at the Loews Miami Beach in Miami, Florida.  Jon Russell, Vice President, Finance, will attend.  Mr. Russell's presentation is scheduled for Tuesday, March 2, 2010 at 11:00 a.m.  

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life.  A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health.  Inverness is headquartered in Waltham, Massachusetts.  

SOURCE Inverness Medical Innovations, Inc.